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Background: Acute respiratory illness, a leading cause of cough in children, accounts for a substantial proportion
of childhood morbidity and mortality worldwide. In some children acute cough progresses to chronic cough
(>4 weeks duration), impacting on morbidity and decreasing quality of life. Despite the importance of chronic
cough as a cause of substantial childhood morbidity and associated economic, family and social costs, data on the
prevalence, predictors, aetiology and natural history of the symptom are scarce. This study aims to comprehensively
describe the epidemiology, aetiology and outcomes of cough during and after acute respiratory illness in children
presenting to a tertiary paediatric emergency department.
Methods/design: A prospective cohort study of children aged <15 years attending the Royal Children’s Hospital
Emergency Department, Brisbane, for a respiratory illness that includes parent reported cough (wet or dry) as a
symptom. The primary objective is to determine the prevalence and predictors of chronic cough (≥4 weeks
duration) post presentation with acute respiratory illness. Demographic, epidemiological, risk factor, microbiological
and clinical data are completed at enrolment. Subjects complete daily cough dairies and weekly follow-up contacts
for 28(±3) days to ascertain cough persistence. Children who continue to cough for 28 days post enrolment are
referred to a paediatric respiratory physician for review. Primary analysis will be the proportion of children with
persistent cough at day 28(±3). Multivariate analyses will be performed to evaluate variables independently
associated with chronic cough at day 28(±3).
Discussion: Our protocol will be the first to comprehensively describe the natural history, epidemiology, aetiology
and outcomes of cough during and after acute respiratory illness in children. The results will contribute to studies
leading to the development of evidence-based clinical guidelines to improve the early detection and management
of chronic cough in children during and after acute respiratory illness.
Keywords: Acute respiratory illness, Chronic lung disease, Chronic cough, Paediatric emergency department* Correspondence: k.ogrady@uq.edu.au
†Equal contributors
1Queensland Children’s Medical Research Institute, The University of
Queensland, Level 4, Foundation Building, Royal Children’s Hospital, Herston
Road, Brisbane, Herston QLD 4029, Australia
Full list of author information is available at the end of the article
© 2013 Drescher et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Drescher et al. BMC Pediatrics 2013, 13:125 Page 2 of 9
http://www.biomedcentral.com/1471-2431/13/125Background
Acute respiratory illness (ARI) a leading cause of cough
in children accounts for a substantial proportion of
childhood morbidity and mortality worldwide [1-3].
Cough in children is one of the most common reasons
for medical encounters both in Australia [4] and inter-
nationally [5,6]. In the UK, 30% of all paediatric primary
care encounters are due to respiratory illnesses, with
cough as a symptom accounting for over 8% of all
medical presentations [6]. In the United States, cough as
a symptom is the 4th leading reason for emergency
department (ED) attendance across all ages, accounting
for 3% of all presentations [5]. In a UK study designed to
test the repeatability of a parent-completed respiratory
questionnaire, one third of parents with young children
reported cough in the absence of a cold whilst one in
five parents reported cough at night [7].
Cough in children is symptomatic of a broad range of
respiratory illnesses and infections ranging from mild
and transient upper respiratory tract infections to
serious chronic disease [8]. In some children acute
cough can lead to chronic cough (defined as cough
lasting >4 weeks), which may be the sole presenting
symptom of an underlying respiratory illness. Parents
of children with chronic cough typically seek five or
more medical consultations prior to referral to respira-
tory specialists [9]. Despite chronic cough in children
accounting for substantial direct and indirect costs
for health service providers, patients and their families,
it remains an under-recognised and inadequately
researched cause of morbidity in children [9].
One of the constructs in the assessment of chronic
cough in children is cough quality which includes dry and
wet cough [10]. Chronic wet cough is a key symptom of
protracted bacterial bronchitis (PBB), chronic suppurative
lung disease (CSLD) and bronchiectasis in children and if
left untreated may progress to irreversible lung injury and
chronic lung disease [11,12]. PBB is clinically defined as
the presence of an isolated chronic wet cough in the
absence of pointers suggestive of alternative causes that re-
solves with appropriate antibiotic treatment [11,13]. CSLD
is a clinical syndrome of chronic endobronchial suppu-
ration characterised by a chronic wet cough with or without
evidence of bronchiectasis on a chest high-resolution com-
puted tomography (cHRCT) scan whereas, bronchiectasis
refers to CSLD with the presence of radiological features
[13]. Whether these conditions are different or reflect
severity as part of a spectrum is yet to be determined.
Despite the impacts of chronic cough in children, data
on the prevalence, natural history and development of
chronic cough (particularly that which distinguishes be-
tween wet and dry cough) following ARI are scarce. A
UK study examining the duration of acute cough in pre-
school children presenting to primary care facilities foundthat in 10% of children cough persisted beyond 25 days
[14]. A systematic review conducted by the same lead re-
searchers reports that 10% of children were still coughing
at 20–21 days [15]. Neither of these publications detailed
cough type (wet or dry), the predictors of cough persist-
ence or the outcomes (i.e. diagnosis or treatment) beyond
the stated time points. A later study conducted in New
Zealand however found that 74% of children <2 years of
age had a history of chronic moist cough, moist cough or
crackles and/or an abnormal chest x-ray 10–14 months
after admission with severe lower respiratory tract infec-
tion [16]. Furthermore, there are no data detailing the
types of ARIs that children present with in which a pre-
existing chronic cough may be overlooked.
Inaccurate diagnosis and inappropriate investigation
and management of chronic cough in children are not
uncommon [17]. Misdiagnosis of asthma occurs and the
diagnostic process is further complicated by the fact that
the co-existence of asthma is not uncommon [11,18].
There is a clear need to improve chronic cough manage-
ment in children, with guidelines now available in
Australia and internationally [13,19,20]. However, these
guidelines are not applicable to children presenting with
ARI and associated cough to the ED setting.
EDs may be the sole primary health care provider for
many families with children suffering from ARIs and as-
sociated cough and/or the alternative provider if the
child does not improve after attendance at a general
practitioner or other primary health care provider. A
study conducted in 2012 by Liberman and colleagues
[21] reported substantially low rates of primary care
follow-up at both 7 and 30 days post attendance at a
paediatric ED with ARI. This, in combination with the
potential to progress to chronic cough, highlights the
need for data that aims to inform evidence-based paedi-
atric cough management guidelines specific to this
population.
Despite the importance of cough as a cause of sub-
stantial childhood morbidity and associated economic,
family and social costs, data on the aetiology and natural
history of the symptom are scarce. Additionally, there
are no data on the predictors of chronic cough in chil-
dren following ARI. Consequently evidence-based cli-
nical management guidelines to prevent chronic cough
or to facilitate its early detection and management during
and after ARI in this population are lacking. The avail-
ability of such data may assist in the development of
evidence-based guidelines to improve the early detection
and management of chronic cough in at-risk children
during and after ARI.
Aims and objectives
This paper aims to comprehensively describe the protocol
employed to investigate the natural history, epidemiology,
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children presenting to a tertiary paediatric ED. The data
collected will potentially inform studies leading to the
development of evidence-based clinical guidelines to
improve the early detection and management of chronic
cough in children.
The primary objective of this study is to determine the
prevalence of parent reported chronic cough (≥4 weeks
duration) amongst children at 28 days following presen-
tation with ARI to a tertiary paediatric ED. Secondary
objectives are:
 To determine the prevalence of parent reported
chronic cough by type (wet or dry) amongst
children at 28 days following presentation with ARI
to a tertiary paediatric ED
 To determine the prevalence of underlying lung
disease (PBB, CSLD or bronchiectasis) amongst
children with ARI presenting to a tertiary
paediatric ED
 To identify predictors/risk factors independently
associated with chronic cough at 28 days following
presentation to a tertiary paediatric ED with ARI
 To identify viral and bacterial pathogens associated
with ARI at presentation to a tertiary paediatric ED
 To identify upper airway viral and bacterial
pathogens associated with chronic cough at 28 days
following presentation to a tertiary paediatric ED
with ARI
Methods/design
Setting
The Royal Children’s Hospital (RCH), Brisbane, Australia,
was chosen for the setting of this cohort study as it is the
largest tertiary paediatric public hospital in the state. The
ED services an average of 29000 children per year. Ap-
proximately 4116 (14%) presentations per year are for re-
spiratory complaints, with 2220 (54%) of these reporting
cough as a symptom (RCH, unpublished ED triage data,
2010). The ED has ready access to full diagnostic services
and, amongst other services, the RCH operates a large ter-
tiary paediatric respiratory medicine service.
Research team
The research team responsible for inception, implemen-
tation, actioning and management of the protocol in-
cludes paediatric specialists in the fields of respiratory
and ED medicine, microbiology, epidemiology, nursing
and biostatistics. A team of clinical nurses from the
Paediatric Emergency Research Unit (PERU) at the RCH
ED are responsible for participant recruitment and base-
line data collection. A study specific research assistant
completes participant follow-up, data entry and attends
to daily study requirements such as the booking ofspecialist reviews. A paediatric respiratory specialist is
responsible for the review and assessment of children
with chronic cough at 28 days post enrolment.
Study design
A prospective cohort study of children aged <15 years
attending the RCH ED for a respiratory illness that in-
cludes parent reported cough (wet or dry) as a symptom.
Enrolled children are followed for 28 days post ED pres-
entation to ascertain cough status following ARI. Chil-
dren with persistent cough at day 28 (i.e. no more than a
3 day break in cough during the follow-up period) will
undergo a respiratory assessment within 2 weeks by a
paediatric respiratory physician.
The study protocol has been approved by the Queensland
Children’s Health Services Human Research Ethics
Committee (HREC/11/QRCH/83) and by the Medical Re-
search Ethics Committee of the University of Queensland
(2012000700). Standard operating procedures for all study
operations have been developed and implemented in
accordance with International Conference on Harmo-
nisation - Good Clinical Practice [22] guidelines and the
National Health and Medical Research Council’s (NHMRC)
[23] ethical guidelines.
Recruitment
Participant recruitment for the study began in December
2011 and will continue through until July 2015 to ac-
count for annual variations in ARI prevalence. Children
presenting to the RCH ED with a possible respiratory ill-
ness (cough and/or fever) are identified by a PERU nurse
at the time of triage (Monday-Saturday, between 0600–
2100 hours) for potential participation in the study. The
PERU nurse then assesses the child for eligibility
through medical record review, discussion with the
treating medical team and/or parent/guardian. The
PERU nurse then invites eligible children and their par-
ents to the study via the provision of child and parent
specific plain language statements. Written informed
consent from parents/guardians and assent from chil-
dren aged ≥12 years is obtained in accordance with the
Declaration of Helsinki [24] and NHMRC [23] guide-
lines. All children presenting to the RCH ED with a pos-
sible respiratory illness are recorded on a detailed
screening log by a PERU nurse. This log contains de-
identified demographic and ED triage data as well as the
reason for non-participation in the study (eg; ineligible,
refused, presented outside of recruitment hours).
Inclusion criteria
Age <15 years; parent reported cough as a symptom,
and; present in the ED between the hours of 6am and
9pm (or an inpatient ward within 24 hours post ED
presentation).
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Known diagnosis of chronic lung disease (excluding
asthma); immunosuppressive condition; use of immuno-
modulating drugs (other than oral or inhaled steroids)
in the 30 days prior to presentation, and; insufficient
English to understand the requirements of the study.Study participation
Figure 1 provides an overview of subject participation.
Subjects participate for 28(±3) days following initial pres-
entation at the ED. Enrolment into the study has no bear-
ing on the medical care provided to children in the ED
which is conducted separately and in accordance with
hospital policies and procedures. Parents are also encour-
aged to practice normal healthcare seeking behaviours
throughout the duration of their participation. Children
with parent reported persistent cough at day 28 (no cessa-
tion in cough for >3 consecutive days) are reviewed by aFigure 1 Subject participation.study specific paediatric respiratory physician within 2
weeks. Participation for those children ends once special-
ist review and any relevant investigations are complete.
Children may enrol more than once provided they still
satisfy inclusion and exclusion criteria.Procedures
Table 1 provides an overview of study procedures and data
collected. At enrolment a PERU nurse completes a com-
prehensive questionnaire with the child and their guardian
(published as an online addendum; Additional file 1). Data
is obtained and recorded through parental interview, con-
sultation with the treating medical team and through the
retrieval of information from medical notes and hospital
software packages. Demographic, epidemiological, and
clinical data are recorded, including but not limited to;
presentation symptomology, healthcare utilisation prior to
ED presentation (alternative, primary and tertiary care
Table 1 Outline of study procedures and data collected
Day
0
Day
7
Day
14
Day
21
Day
28
Specialist
review
Screening X
Assess eligibility criteria X
Informed consent X
Demographic data X
Epidemiological data X
Risk factor data X
Cough score, type and
persistence data
X X X X X X
Healthcare utilisation
data
X X X X X X
Medication use data X X X X X X
Parent and child
absenteeism
X X X X X X
Nasal swab X X
Clinical treatment data X X
Clinical investigations X X
Specialist review
management plan
X
Specialist review
outcomes
X
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use, ED clinical management, treatment and diagnosis,
clinical investigation results and socioeconomic status.
Historical variables and those previously described as risk
factors for paediatric ARI and lung disease will also be
collected at enrolment, including; past respiratory history,
familial history of atopy, asthma and lung disease, house-
hold information (e.g. number of occupants), pregnancy
related factors (e.g. gestational age and birth weight),
tobacco smoke exposure and being of Aboriginal or
Torres Strait Islander decent. In cases where the child was
admitted to a RCH ward post ED discharge, basic hospi-
talisation data will also be collected, including; primary
and secondary diagnoses, length of stay, clinical investi-
gation data and respiratory medicine consultations. A
bilateral anterior nasal swab will be collected (or a sam-
ple of nasopharyngeal aspirate if obtained during clinical
care).
Parents are also asked to complete a previously vali-
dated verbal category descriptive (VCD) [25] score
cough diary card for 28 days post enrolment. The
recruiting PERU nurse provides the parent with both
verbal and written instruction on how to complete the
dairy card and a reply paid envelope to facilitate diary
return. Parents also receive weekly dairy reminders via
phone or email. Diary items include, cough persistence
and frequency, medication use, and whether or not they
sought further medical advice for the cough. If the diary
card shows that the child has not stopped coughing fora period of greater than three consecutive days during
the 28 day follow-up period, he/she will be referred to a
study specific paediatric respiratory specialist at the
RCH within 2 weeks for further investigation and
management.
Follow-up contacts, via phone or email are also conducted
by a study specific research assistant with parents at day
7, 14, 21 and 28(±3). Three contact attempts are made at
each follow-up time point. If at any time point a contact
is unsuccessful, a diary card reminder is still issued and
each successive contact attempted. These contacts are
used to ascertain parent reported cough persistence and
type, parental absence from work due to their child’s
cough, missed day-care/school due to cough and whether
or not the child’s cough has ceased for a period of greater
than three consecutive days during the follow-up period.
In cases where a diary card is not returned, cough persis-
tence information gathered at these contacts will identify
children requiring specialist review.
At specialist review a comprehensive assessment is
completed in accordance with current cough manage-
ment guidelines [13,19]. Assessment items include, but
are not limited to; cough persistence, frequency and
type, physical examination for chest wall deformity and
clubbing, chest sound auscultation, spirometry (where
age appropriate) and a repeat bilateral anterior nasal
swab. Other investigations such as chest imaging (x-ray
or cHRCT), immunological work-up, sweat chloride
testing and bronchoscopy are performed as clinically in-
dicated. Study participation for these children ends once
all relevant investigations are complete and an appropri-
ate management or treatment plan is in place.
Laboratory methods
Bilateral anterior nasal swabs will be stored at −80°C
within 24 hours of collection and transferred to the
Queensland Paediatric Infectious Diseases Laboratory,
Royal Children’s Hospital, Brisbane, for viral and bacte-
rial identification by polymerase chain reaction (PCR)
testing.
Bacterial PCR testing will include M. pneumonia, S.
pneumoniae, nontypeable Haemophilus influenza and
M. catarrhalis. A 16S signature sequence will be used to
detect all strains of Chlamydiales as an initial screen
before positive specimens are tested for specific C.
trachomatis, C. pneumoniae and S. negevensis sequences.
PCR testing will further detect 17 viruses associated with the
human respiratory tract including; adenovirus, respiratory
syncytial virus, influenza virus types A & B, parainfluenza
virus types 1–3, human metapneumovirus, human rhinovi-
ruses, human coronaviruses (OC43, 229E, NL63 + HKU1),
human bocavirus and human polyomaviruses KI and WU
as per published methods [26-30]. Should more than one
respiratory viral or bacterial pathogen simultaneously appear
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cleic acids may help identify the dominant agent within
these classes of pathogens by comparing cycle threshold
(Ct) values [31]. The dominant pathogen in each sample is
identified as that with a Ct-value at least 3 cycles lower than
the Ct-values for any other respiratory pathogen [31].
Data handling and storage
Data collected over the study duration are recorded in a
paper based case report form and later entered into a
password protected FileMaker Pro Advanced V12
(FileMaker Inc, Santa Clara, California) database. Copies
of source documents, such as investigation results, are
filed in the participants individual study folder and en-
tered into the electronic database. At participant com-
pletion a file audit is completed in which paper based
and electronic records are checked for consistency, com-
pleteness and accuracy of data. Data query forms are
completed for any discrepancies and returned to the ap-
propriate study staff for correction. Following this the
chief investigator reviews all participant files and ap-
proves them for signoff and storage. All study folders are
stored in a locked secure cabinet. Access to identifiable
participant information is only provided to immediate
study staff unless otherwise required by legislative or
regulatory agencies.
Sample size
The RCH ED has an average of 343 presentations per
month for respiratory complaints of which 185 (54%)
have cough recorded as a symptom (RCH, unpublished
ED triage data, 2010). One hundred and forty eight
(80%) of these presentations occur during study recruit-
ment hours (6am to 9pm) (RCH, unpublished ED triage
data, 2010) and thus, assuming a 70% enrolment, pro-
vides a potential sample of 1243 participants per year.
As the prevalence of persistent cough amongst children
with ARI is unknown, an estimated prevalence of 50%
was used for sample size calculation to produce the
highest estimate. To address the primary objective and
detect a prevalence of 50% per year (α=0.05 and 95%
confidence interval) assuming a 30% loss-to-follow-up,
an annual minimum of 500 children with complete data
at day 28 is required. Bi-monthly reviews are completed
to evaluate recruitment progression and interventions
implemented where required.
Data analysis
Descriptive analyses including demographic, clinical, la-
boratory and risk factor data will be tabulated and
expressed as proportions and/or means of the selected
characteristics with the corresponding 95% confidence in-
tervals. Where continuous data are not normally distrib-
uted, medians with accompanying interquartile ranges willbe presented. The primary analysis will be the proportion
of children with persistent cough at day 28(±3) post pres-
entation to the ED with a respiratory illness. Differences
in demographic, clinical, laboratory and risk factor data
between children with and without cough at day 28(±3)
will be assessed using two sided t-tests for the comparison
of means and chi-square tests for the comparison of
proportions. Where data are not normally distributed
non-parametric methods, such as a Mann–Whitney U
test, will be used. Multivariate analyses, for example, a
generalised linear model with logit link, will be performed
to evaluate variables independently associated with
chronic cough at day 28(±3).
Laboratory data arising from nasal swabs will be
analysed for each study time point (enrolment and specia-
list review). Individual pathogens, their proportions and
corresponding 95% confidence intervals will be tabulated
and presented. These analyses will be conducted by indi-
vidual pathogen and any pathogen overall and will ac-
count for variation in bacterial and/or viral load, mode of
collection (nasal swab or nasopharyngeal aspiration) and
the quality of specimen collection (as reported by the
collecting nurse). The association between bacterial and
viral co-infection and chronic cough will be explored
through multiple regression models after adjusting for
potential confounders.
Discussion
This study will be the first to comprehensively describe the
natural history, epidemiology, aetiology and outcomes of
chronic cough, during and after ARI in children. Our
prospective cohort study design in conjunction with a
comprehensive clinical, epidemiological and microbio-
logical approach will enable the collection of data that will
address issues at both the time of presentation and during
the recovery phase. Results will be published in national
and international peer-reviewed journals and where appro-
priate presented at relevant conferences. We believe the
dissemination of our results will contribute to future
research aiming to develop and/or review new and existing
evidence-based paediatric cough management guidelines.
Rationale for study endpoints
There are limited studies that have evaluated the pro-
gression to chronic cough post ARI and none that have
differentiated between wet and dry cough. Similarly
there are limited data from select populations on the
predictors of, and microorganisms associated with,
chronic cough post ARI. The definition of chronic cough
used here is a cough lasting >4 weeks. This definition is
consistent with both prior research [8,14,15] and the
American College of Chest Physicians guidelines for
evaluating cough in children [19]. A break in cough of
greater than 3 consecutive days was incorporated into
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subsequently become unwell with a second cough illness
are not misclassified as having chronic cough. The con-
tinued participation of children until day 28 regardless
of cough persistence will elicit data on the frequency of
cough reoccurrence post ARI recovery and allows a
more comprehensive comparison of children who do
and do not continue to cough during the follow-up
period.
Furthermore, ARIs in children are commonly the result
of bacterial and viral infections. However, very few chil-
dren presenting to the ED (or primary care settings) with
ARI undergo bacterial and viral testing. The collection of
bilateral anterior nasal swabs on all study children will
identify viral and bacterial pathogens associated with ARI
and cough at both the time of ED presentation and spe-
cialist review. An extended panel of known respiratory
pathogens (previously discussed) was chosen to ensure
that pathogens excluded from routine respiratory PCR
testing in the ED were included for analysis and contribute
to the literature on pathogens for which the association
between nasal detection and clinical illness is still being
explored (e.g. polyomaviruses) [32]. Using an extended
panel also enhances our ability to explore viral and bacter-
ial interactions and their effects on cough outcomes.Limitations
Selection bias
Given funding, feasibility and logistic constraints only
children present at the RCH between the hours of 6am to
9pm will be approached for participation. Children and
their families attending the ED outside of these hours may
differ from those attending during these hours. De-
identified demographic and ED triage data will be collated
and analysed to assess the extent to which children who
were potentially eligible but not enrolled may bias the
study findings. Furthermore, a difference may exist
between families who seek care through the ED and those
who attend primary care facilities.
Given that families may attend multiple healthcare facil-
ities for management of the same illness, that many families
seen in the ED are referred from other healthcare settings
and that EDs are commonly used as a substitute for pri-
mary care services [33-35], the effects of restricting recruit-
ment to a tertiary ED on the results are likely to be limited.
Collection of illness severity, symptom, ED triage and prior
healthcare utilisation data at enrolment will enable assess-
ment and description of how our results may be biased.
Furthermore, as recruitment is restricted to one tertiary
paediatric ED in Brisbane, Queensland, Australia, the re-
sults are likely to be more representative of children living
in urban communities and developed countries with tem-
perate climates.It is also plausible that parents of children with recur-
rent cough are more likely to enrol and complete the
study, potentially overestimating the prevalence of chronic
cough at day 28. Additionally, it is possible that children
with existing undiagnosed chronic lung disease may be
enrolled in the study also inflating the prevalence of
chronic cough. Data pertaining to the child’s past respira-
tory health in conjunction with a comprehensive assess-
ment of children with persistent cough at specialist review
will allow assessment of this potential bias. It is possible
these children will be amongst those referred for respira-
tory physician review and the identification of these chil-
dren will be an important study outcome.
There is also the potential of bias derived from loss-to-
follow-up, particularly as those who complete the study
may differ from those who do not. Demographical, epi-
demiological, risk factor and clinical data collected at en-
rolment in combination with weekly cough persistence
data will permit sensitivity analyses to assess the impact of
this bias on study outcomes.
Measurement bias
Parent proxy reporting via a diary card using a VCD score
is the chosen method for obtaining cough persistence data
over the follow-up period. Although it is possible to col-
lect the same data using objective measures, for example
through use of ambulatory cough meters, they are not
feasible as analysis is resource heavy. Furthermore, given
the intended size of our cohort it was not feasible in terms
of cost or practicality. Chang et al. [25], report that VCD
diary cards have the highest correlation to cough fre-
quency when measured objectively and hence, can be used
in the absence of practical objective measures to evaluate
cough severity and persistence.
Parental report is also used to determine cough type over
the follow-up time period. It is possible that some mis-
classification will occur, although this is likely to be limited.
Chang et al. [36], found that parental assessment of
cough type had excellent agreement with that of clini-
cians (K= 0.75, 95% CI: 0.58-0.93) and that clinicians'
assessments were only marginally better than that of par-
ents when compared to bronchoscopic findings. At special-
ist review (where required), both the parent and treating
physician report on cough type allowing for the assessment
of inter-rater reliability and the potential for derived bias.
Furthermore, on any given day in the ED there are nu-
merous different clinicians with differing levels of ex-
pertise and experience. Consequently, diagnosis, clinical
investigations performed and treatment initiated may
vary significantly across physicians. The collection of de-
tailed symptom, treatment and clinical data, as well as
the collection of study specific anterior nasal swabs will
minimise the effect of any potential bias by reducing
dependence on clinician directed data. Furthermore,
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spiratory specialists from the same centre, the potential
for bias derived from inconsistency of diagnosis at the
time of specialist review will be minimised.
Conclusion
Chronic cough is an under-recognised and inadequately
researched cause of morbidity and decreased quality of life
in children. This study will describe the natural history,
epidemiology, aetiology and outcomes of chronic cough in
children presenting to a tertiary paediatric ED. Our results
will inform studies for evidence-based guidelines to im-
prove the early detection, prevention and management of
chronic cough in children during and after ARI.
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